Tabula Rasa HealthCare Inc (TRHC) Insider Andrea Carolan Speers Sells 1,022 Shares

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) insider Andrea Carolan Speers sold 1,022 shares of the stock in a transaction dated Thursday, January 3rd. The shares were sold at an average price of $58.08, for a total value of $59,357.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

NASDAQ:TRHC opened at $66.00 on Monday. Tabula Rasa HealthCare Inc has a 52-week low of $28.55 and a 52-week high of $91.16. The company has a market cap of $1.35 billion, a P/E ratio of -1,650.00, a PEG ratio of 4.20 and a beta of 2.45. The company has a current ratio of 0.49, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a positive return on equity of 7.63% and a negative net margin of 13.49%. The company had revenue of $54.42 million for the quarter, compared to the consensus estimate of $52.87 million. During the same period last year, the business posted $0.08 EPS. The company’s revenue was up 66.3% on a year-over-year basis. On average, research analysts expect that Tabula Rasa HealthCare Inc will post 0.42 EPS for the current fiscal year.

A number of research firms have recently commented on TRHC. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “sell” rating to a “buy” rating and set a $69.00 price objective on the stock in a report on Thursday. Benchmark began coverage on Tabula Rasa HealthCare in a report on Tuesday, January 8th. They issued a “buy” rating and a $85.00 price objective on the stock. BidaskClub downgraded Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. Piper Jaffray Companies reiterated an “overweight” rating and issued a $80.00 price objective on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. Finally, Chardan Capital increased their price objective on Tabula Rasa HealthCare from $77.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, November 7th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Tabula Rasa HealthCare has a consensus rating of “Buy” and an average target price of $82.27.

Hedge funds have recently made changes to their positions in the business. Sei Investments Co. acquired a new stake in shares of Tabula Rasa HealthCare in the 2nd quarter valued at approximately $1,098,000. Rhumbline Advisers raised its holdings in Tabula Rasa HealthCare by 34.5% during the second quarter. Rhumbline Advisers now owns 36,119 shares of the company’s stock worth $2,305,000 after purchasing an additional 9,272 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in Tabula Rasa HealthCare during the second quarter worth $207,000. State Board of Administration of Florida Retirement System acquired a new position in Tabula Rasa HealthCare during the second quarter worth $428,000. Finally, Bank of New York Mellon Corp raised its holdings in Tabula Rasa HealthCare by 34.2% during the second quarter. Bank of New York Mellon Corp now owns 214,062 shares of the company’s stock worth $13,664,000 after purchasing an additional 54,507 shares during the last quarter. Institutional investors own 74.87% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/01/14/tabula-rasa-healthcare-inc-trhc-insider-sells-59357-76-in-stock.html.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Read More: What is the downside to momentum investing?

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply